The ‘2023 ICPI Week (International Pharmaceutical and Cosmetics Week)’ exhibition, which provides a glimpse into the entire supply chain from pharmaceutical and cosmetic development to manufacturing and logistics distribution, was held at KINTEX Exhibition Hall 18 in Goyang on the 1th. This exhibition will be held under the supervision of Gyeongyeon Exhibition and KY Expo, the organizers of the exhibition, and will run until the 21st (Friday).
At this exhibition, raw drug, finished drug, and fine chemical companies from India, a pharmaceutical and fine chemical production powerhouse, will exhibit as a group at ‘Korea Pharm & Bio 2023’ and ‘Korea Chem 2023’. prepared. This trade group is comprised of 3 member companies from three export promotion organizations under the Indian government, including the Indian Pharmaceutical Import and Export Association (Pharmexcil), the Indian Pharmaceutical Association (IDMA), and the Indian Basic Chemicals, Cosmetics and Fine Chemicals Promotion Council (Chemexcil).
In addition, the Indian trade group provided a venue to introduce its members to Korea through this exhibition, and held an international forum and B2B consultation for business collaboration between Korean and Indian bio and fine chemical companies.
In order to seek international cooperation with the Korean pharmaceutical and bio industries, the Indian Embassy in Korea (Ambassador Amit Kumar) held the ‘Korea-India Pharmaceutical Business Forum and B19B Consultation’ in rooms 1 and 306 of KINTEX Exhibition Hall 307 on the 2th (Wednesday), the second day of the exhibition. Hosted and supported. This forum, which was held to develop the pharmaceutical sector in both countries, strengthen business partnerships between industries, and form networking, included presentations on the current status of the pharmaceutical industry and regulatory policies in both countries, an MOU signing ceremony, and a networking lunch. At the India exhibition booth set up in KINTEX Exhibition Hall 1, Korea’s 1:1 B2B meetings were held with pharmaceutical, cosmetics, and fine chemical manufacturers, distributors, and importers.
Jang Byeong-won, vice president of the Korea Pharmaceutical and Biotechnology Association, who participated in the forum on this day, said, “The COVID-19 pandemic that has struck the world has once again reminded us all of the importance of the pharmaceutical and bio industry. “The pharmaceutical and bio industries play a very important role as a social safety net that protects the precious lives and health of humanity along with the country’s economic growth.” It made us realize once again the importance of international cooperation to protect . “It taught us a lesson that a supply chain that is absolutely dependent on some countries can threaten the lives and health of people in the event of a public health crisis,” he emphasized.
At a time when we need to learn from the Corona pandemic and prepare a global response system for the next pandemic, Vice Chairman Jang said, “With this recognition and search for alternatives, India will become a very important partner for Korea. In particular, India is the world’s third largest pharmaceutical manufacturing country, and I understand that the Indian government is pursuing ‘Pharma Vision 3’, which aims to make India a leader in global pharmaceutical manufacturing, from raw medicines to finished medicines,” he said. Excluding the United States, it is the country with the largest number of FDA certifications for pharmaceuticals, and based on its long history, the level of research and development personnel is also very high. “There are great expectations for India’s role in the global pharmaceutical and bio industry,” he said.
He continued, “Korea is also leaping forward as an emerging powerhouse in the pharmaceutical and bio industries. The pipeline of new drugs currently under development has reached approximately 4, a three-fold increase over the past four years. “Medicine exports and new drug technology transfer are also showing a continuous increase,” he said. “The government has also expressed its will to actively foster the pharmaceutical and bio industries by selecting them as national core strategic industries along with semiconductors, future cars, secondary batteries, and aerospace industries.” “There is,” he emphasized.
Vice Chairman Jang said, “There is already a close cooperative relationship between the pharmaceutical and bio industries between the two countries. In addition, a number of companies, including association member companies such as Daewoong Pharmaceutical and Dong-A ST, are in earnest entering India by establishing R&D centers or local corporations in India,” he said. “This forum will serve as an opportunity to strengthen the relationship between the pharmaceutical and bio industries of the two countries.” We hope that ties and cooperation will become stronger. In addition, we hope that today’s event will be a meaningful opportunity for mutual growth between participating companies in Korea and India through active discussion and information sharing. “The Korea Pharmaceutical and Biotechnology Association will also do its best to develop the pharmaceutical and bio industries of the two countries and strengthen cooperation,” he said.
Meanwhile, the ‘2023 ICPI Week (International Pharmaceutical and Cosmetic Week)’ exhibition, which allows you to look at the entire supply chain from pharmaceutical and cosmetic development to manufacturing and distribution in one place, is held at ▲International Pharmaceutical and Bio Industry Exhibition (KOREA PHARM) & BIO) ▲International Cosmetic Raw Materials and Technology Exhibition (CI KOREA) ▲International Research, Experiment and Analysis Equipment Exhibition (KOREA LAB) ▲International Chemical Equipment Industry Exhibition (KOREA CHEM) ▲International Pharmaceutical, Bio and Cosmetic Technology Exhibition (COPHEX) ▲International Logistics Industry Daejeon (KOREA MAT) ▲It consists of the International Cold Chain Industry Exhibition (KOREA COLD CHAIN).
→ Go to ‘2023 ICPI Week (International Pharmaceutical and Cosmetics Week)’ news special page